PROTALIX BIOTHERAPEUTICS INC

Historical 13F Holders

Symbol
PLX
CUSIP
74365A309
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 74365A309 since 12/18/2024, newest first.

Filer % of Class Filed
HOLD Alapkezelo Zrt. 13G 5.2% 10/15/2026
Event 10/14/2026
BlackRock, Inc. 13G 5.0% 7/29/2026
Event 6/30/2026
MAK Capital Fund LP 13G/A Amendment 1
4.5% 3/30/2026
Event 3/24/2026
MAK Capital Fund LP 13G
5.8% 3/4/2026
Event 2/26/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 13 235 k $646 k
2026 Q2 107 14.5 M $34.7 M
2026 Q1 106 16.9 M $36.6 M
2025 Q4 85 14.9 M $26.8 M
2025 Q3 83 14.0 M $31.0 M
2025 Q2 68 11.9 M $17.6 M
2025 Q1 69 8.19 M $21.0 M
2024 Q4 49 4.47 M $8.40 M
2024 Q3 50 3.44 M $3.53 M
2024 Q2 73 5.73 M $6.70 M
2024 Q1 71 9.84 M $12.4 M
2023 Q4 76 10.3 M $18.3 M
2023 Q3 67 9.17 M $15.2 M
2023 Q2 74 8.98 M $17.9 M
2023 Q1 40 2.94 M $6.15 M
2022 Q4 32 3.57 M $4.87 M
2022 Q3 31 3.55 M $3.70 M
2022 Q2 35 1.19 M $1.30 M
2022 Q1 37 1.22 M $1.29 M
2021 Q4 41 3.02 M $2.52 M
2021 Q3 46 4.42 M $5.91 M
2021 Q2 44 4.56 M $8.71 M
2021 Q1 48 8.82 M $39.4 M
2020 Q4 30 4.14 M $15.0 M
2020 Q3 32 4.77 M $18.5 M
2020 Q2 33 5.27 M $19.9 M
2020 Q1 23 6.00 M $14.1 M
2019 Q4 16 646 k $2.12 M